|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/439 | |
| A61K 31/46 | |||
| A61P 25/20 |
| (11) | Patento numeris | 2945626 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13705591.9 |
| Europos patento paraiškos padavimo data | 2013-01-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/050368 |
| Data | 2013-01-15 |
| (87) | Numeris | WO 2014/111751 |
| Data | 2014-07-24 |
| (72) |
FENDT, Markus, CH
FEUERBACH, Dominik, CH
GOMEZ-MANCILLA, Baltazar, CH
LOPEZ-LOPEZ, Cristina, CH
MCALLISTER, Kevin Hall, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF ALPHA 7 NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF NARCOLEPSY |
| USE OF ALPHA 7 NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF NARCOLEPSY |